Advanced Enzyme Technologies is coming out with a 100% book building; initial public offering (IPO) of 46,02,651 shares of Rs 10 each in a price band Rs 880-896 per equity share. The issue will open for subscription on July 20, 2016 and will close on July 22, 2016.
The company will use the issue proceed for investment in Advanced Enzymes USA, wholly owned subsidiary of the company for repayment / pre-payment of certain loans availed by Advanced Enzymes USA and general corporate purposes.
The book running lead managers to the issue are ICICI Securities and Axis Capital, while the compliance officer for the issue is Prabal Bordiya.
Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: